Publications by authors named "Tzu-Peng Cheng"

Claim this Profile
R
Revisiting COX-2 inhibitors for Alzheimer's disease as multitargeted ligands: Development of 4-hydrazono-pyrazolidinediones with tuned COX selectivity profile and improved cellular potency.
Reham Waheed, Zeinab Mostafa, Michael Emad, Sarah S Darwish, Rosa Purgatorio, Tzu-Peng Cheng, Yu-Cheng Chen

Eur J Med Chem· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring pyrazolidinone and pyrazolidinedione scaffolds for Alzheimer's therapy: multitarget COX-2 inhibitors with anti-amyloid β, anti-tau, antioxidant, and neuroprotective activities.
Michael Emad, Reham Waheed, Zeinab Mostafa, Sarah S Darwish, Rosa Purgatorio, Tzu-Peng Cheng, Yu-Cheng Chen

RSC Med Chem· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-Inflammatory Saponins From an Edible Aquatic Plant Nymphoides hydrophylla.
Ching-Yeu Chen, Tzu-Peng Cheng, Tsong-Long Hwang, Yong-Siang Hou, Limbadri Salendra, Yuan-Bin Cheng

Phytochem Anal· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Neutrophil-Mediated Inflammation: Identification of Pyrazolidinone Carboxamide Derivatives as Potent Selective Inhibitors of Formyl Peptide Receptor 1 (FPR1)-Activated Neutrophils.
Mohammad Abdel-Halim, Reem A Wagdy, Mohamed Salah, Yi-Hsuan Wang, Tzu-Peng Cheng, Yu-Cheng Chen

ACS Pharmacol Transl Sci· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a novel C2-functionalized chromen-4-one scaffold for the development of p38α MAPK signaling inhibitors to mitigate neutrophilic inflammatory responses.
Yi-Han Chang, Yi-Chen Lee, Shun-Hua Chen, Shu-Yen Fang, Tzu-Peng Cheng

Biochem Pharmacol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis